1. Home
  2. OBIO vs APEI Comparison

OBIO vs APEI Comparison

Compare OBIO & APEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • APEI
  • Stock Information
  • Founded
  • OBIO 2017
  • APEI 1991
  • Country
  • OBIO United States
  • APEI United States
  • Employees
  • OBIO N/A
  • APEI N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • APEI Other Consumer Services
  • Sector
  • OBIO Health Care
  • APEI Consumer Discretionary
  • Exchange
  • OBIO Nasdaq
  • APEI Nasdaq
  • Market Cap
  • OBIO 291.7M
  • APEI 287.2M
  • IPO Year
  • OBIO N/A
  • APEI 2007
  • Fundamental
  • Price
  • OBIO $8.51
  • APEI $19.44
  • Analyst Decision
  • OBIO Strong Buy
  • APEI Buy
  • Analyst Count
  • OBIO 2
  • APEI 3
  • Target Price
  • OBIO $17.00
  • APEI $17.00
  • AVG Volume (30 Days)
  • OBIO 248.5K
  • APEI 383.7K
  • Earning Date
  • OBIO 08-08-2024
  • APEI 08-06-2024
  • Dividend Yield
  • OBIO N/A
  • APEI N/A
  • EPS Growth
  • OBIO N/A
  • APEI N/A
  • EPS
  • OBIO N/A
  • APEI N/A
  • Revenue
  • OBIO $2,216,000.00
  • APEI $605,288,000.00
  • Revenue This Year
  • OBIO $17.90
  • APEI $6.01
  • Revenue Next Year
  • OBIO $10.51
  • APEI $3.46
  • P/E Ratio
  • OBIO N/A
  • APEI N/A
  • Revenue Growth
  • OBIO N/A
  • APEI 0.67
  • 52 Week Low
  • OBIO $4.22
  • APEI $4.05
  • 52 Week High
  • OBIO $11.69
  • APEI $21.04
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 62.57
  • APEI 68.31
  • Support Level
  • OBIO $7.48
  • APEI $16.65
  • Resistance Level
  • OBIO $8.20
  • APEI $17.85
  • Average True Range (ATR)
  • OBIO 0.60
  • APEI 0.90
  • MACD
  • OBIO 0.04
  • APEI 0.22
  • Stochastic Oscillator
  • OBIO 89.59
  • APEI 94.71

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About APEI American Public Education Inc.

American Public Education Inc provides online and on-campus postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.

Share on Social Networks: